Genetically Engineered Cell Lines

Genetically Engineered Cell Lines Overview

genetically engineered cell lines services

With the advancement of gene sequencing and gene editing technologies, an increasing number of new drug targets for cancer are being discovered. Drug testing at the cellular level targeting these new targets is a crucial step in drug discovery. Our expert team has over 20 years of experience in engineering cell lines. We have already constructed over 4,000 genetically edited cell lines, covering a wide range of overexpressed, knocked-in and knocked-out genes related to kinase (based on BaF3 cell line), signaling pathways, immune molecules, tumor antigens, etc. These cell lines support the development of both small molecule and antibody-based drugs for cancer treatment.

Technology

Genetically engineered cell lines

Genetically engineered cell lines revolutionize research, enabling precise studies on diseases, therapies, and biological processes for innovative medical advancements.

In vitro and in vivo pharmacology

In vitro pharmacology explores drug effects in controlled lab settings, while in vivo studies investigate drug responses within living organisms.

Bispecific and tri-specific antibody discovery platform

Revolutionize immunotherapy with our cutting-edge Bispecific and Tri-specific Antibody Discovery Platform, enhancing precision and efficacy in targeted cancer treatments

MPSA-AB5000 panel

Genetically engineered cell lines revolutionize research, enabling precise studies on diseases, therapies, and biological processes for innovative medical advancements.

AI-based antibody development platform

Revolutionize immunotherapy with our cutting-edge Bispecific and Tri-specific Antibody Discovery Platform, enhancing precision and efficacy in targeted cancer treatments